4
Changes in Ownership
CRESCENT BIOPHARMA, INC. Filed Acc 0001209191-16-090751
Options or other derivatives
- VP Clinical Development, CMO acquired 71,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Thackray Helen M. VP Clinical Development, CMO | 2016-01-07 | Grant or award · Employee Stock Option (right to buy) | +71,000 | 71,000 | D: show line 1 in the form |
Loading xslF345X03/doc4.xml…